Schwartz Investment Counsel Inc. bought a new position in shares of Acuren Corp (NYSEAMERICAN:TIC – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 263,946 shares of the company’s stock, valued at approximately $3,513,000.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Swedbank AB purchased a new stake in shares of Acuren during the third quarter valued at approximately $43,923,000. Geode Capital Management LLC purchased a new stake in shares of Acuren during the 2nd quarter valued at $25,003,000. Bernzott Capital Advisors purchased a new stake in shares of Acuren during the 3rd quarter valued at $9,879,000. Goldman Sachs Group Inc. bought a new stake in shares of Acuren during the 1st quarter worth $4,429,000. Finally, Ieq Capital LLC purchased a new position in shares of Acuren in the 2nd quarter worth about $2,208,000.
Wall Street Analyst Weigh In
Several equities analysts recently weighed in on the stock. UBS Group reduced their price target on shares of Acuren from $15.00 to $11.50 and set a “neutral” rating for the company in a research report on Friday, November 14th. Robert W. Baird began coverage on shares of Acuren in a research report on Thursday, October 9th. They set a “neutral” rating and a $15.00 target price for the company. Jefferies Financial Group restated a “buy” rating and set a $15.00 price target on shares of Acuren in a research note on Friday, November 14th. Baird R W upgraded Acuren to a “hold” rating in a research note on Thursday, October 9th. Finally, Zacks Research raised Acuren to a “hold” rating in a report on Tuesday, December 16th. Two equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $14.38.
Acuren Trading Down 1.7%
TIC opened at $11.44 on Monday. The firm has a 50-day moving average price of $10.21 and a 200-day moving average price of $11.22. Acuren Corp has a twelve month low of $8.76 and a twelve month high of $14.94.
Acuren Company Profile
Acuren Group Inc (NYSEAMERICAN:TIC) is a leading provider of non‐destructive testing (NDT), inspection, engineering and consulting services to the energy, petrochemical, manufacturing and infrastructure sectors. The company employs a range of advanced testing techniques—such as ultrasonic, radiographic, magnetic particle, liquid penetrant, eddy current and acoustic emission—to evaluate the integrity of pressure vessels, pipelines, storage tanks and other critical assets. By combining field inspections with laboratory analysis, Acuren helps clients identify defects, prevent equipment failures and meet regulatory requirements.
In addition to core NDT capabilities, Acuren offers specialty engineering and consulting services including fitness‐for‐service assessments, corrosion under insulation surveys, mechanical integrity programs, failure analysis and field machining.
Read More
- Five stocks we like better than Acuren
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- Executive Order 14330: Trump’s Biggest Yet
Want to see what other hedge funds are holding TIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acuren Corp (NYSEAMERICAN:TIC – Free Report).
Receive News & Ratings for Acuren Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acuren and related companies with MarketBeat.com's FREE daily email newsletter.
